Clinical and histopathological features of immune checkpoint inhibitor-related myositis in patients with advanced non-small cell lung cancer  

作　　者：JIANG Juhong 姜桔红(State Key Respir Dis Lab,Guangzhou Respir Health Instit,Natl Clin Respir Dis Res Center,1st Affil Hosp,Guangzhou Med Univ,Guangzhou 510000)

机构地区：[1]State Key Respir Dis Lab,Guangzhou Respir Health Instit,Natl Clin Respir Dis Res Center,1st Affil Hosp,Guangzhou Med Univ,Guangzhou 510000

出　　处：《China Medical Abstracts(Internal Medicine)》2022年第2期103-104,共2页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To investigate the clinicopathologic features and outcome of myositis in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors.Methods The patients diagnosed with immune checkpoint inhibitor-related (ICI) myositis in the database of Respiratory Pathology Center of The First Affiliated Hospital, Guangzhou Medical University from June 2019 to December 2020 were retrospectively analyzed. We reported the muscle histology and main clinical manifestations of the patients in this study.

关 键 词：PATIENTS LUNG cancer 

分 类 号：R734.2[医药卫生—肿瘤]